Astrazeneca plc ADR [NASDAQ: AZN] Sees Increase in Stock Value

As published in a research note from Deutsche Bank on February 08, 2024, Astrazeneca plc ADR [AZN] has been rated down from a Hold to a Sell. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late January. Earlier on January 03, 2024, Jefferies downgraded its rating. […]